These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26969902)

  • 1. Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture.
    Kim SC; Kim DH; Mogun H; Eddings W; Polinski JM; Franklin JM; Solomon DH
    J Bone Miner Res; 2016 Aug; 31(8):1536-40. PubMed ID: 26969902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996-2012: An Ecological Analysis.
    Jha S; Wang Z; Laucis N; Bhattacharyya T
    J Bone Miner Res; 2015 Dec; 30(12):2179-87. PubMed ID: 26018247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
    Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
    N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday.
    Curtis JR; Westfall AO; Cheng H; Delzell E; Saag KG
    Osteoporos Int; 2008 Nov; 19(11):1613-20. PubMed ID: 18483689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates and the risk of atypical femur fractures.
    Black DM; Condra K; Adams AL; Eastell R
    Bone; 2022 Mar; 156():116297. PubMed ID: 34920168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate Use After Hip Fracture in Older Adults: A Nationwide Retrospective Cohort Study.
    Nordström P; Toots A; Gustafson Y; Thorngren KG; Hommel A; Nordström A
    J Am Med Dir Assoc; 2017 Jun; 18(6):515-521. PubMed ID: 28238673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture.
    Wang PW; Li YZ; Zhuang HF; Yu HM; Cai SQ; Xu H; Chen ZH; Lin JK; Yao XD
    Orthop Surg; 2019 Oct; 11(5):777-783. PubMed ID: 31429532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Hip Fracture Despite Treatment with Bisphosphonates among Frail Older Adults.
    Zullo AR; Sorial MN; Lee Y; Lary CW; Kiel DP; Berry SD
    J Am Geriatr Soc; 2020 Feb; 68(2):256-260. PubMed ID: 31580488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.
    Edwards BJ; Bunta AD; Lane J; Odvina C; Rao DS; Raisch DW; McKoy JM; Omar I; Belknap SM; Garg V; Hahr AJ; Samaras AT; Fisher MJ; West DP; Langman CB; Stern PH
    J Bone Joint Surg Am; 2013 Feb; 95(4):297-307. PubMed ID: 23426763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults.
    Zullo AR; Zhang T; Lee Y; McConeghy KW; Daiello LA; Kiel DP; Mor V; Berry SD
    J Am Geriatr Soc; 2019 Apr; 67(4):768-776. PubMed ID: 30575958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate Use and Hospitalization for Hip Fractures in Women: An Observational Population-Based Study in France.
    Bourrion B; Souty C; Fournier L; Vilcu AM; Blanchon T; Böelle PY; Hanslik T; François M
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data.
    Shalev V; Sharman Moser S; Goldshtein I; Yu J; Weil C; Ish-Shalom S; Rouach V; Chodick G
    Ann Pharmacother; 2017 Sep; 51(9):757-767. PubMed ID: 28535690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users.
    Curtis JR; Westfall AO; Cheng H; Lyles K; Saag KG; Delzell E
    J Bone Miner Res; 2008 Sep; 23(9):1435-41. PubMed ID: 18442318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral bisphosphonates are associated with reduced mortality after hip fracture.
    Beaupre LA; Morrish DW; Hanley DA; Maksymowych WP; Bell NR; Juby AG; Majumdar SR
    Osteoporos Int; 2011 Mar; 22(3):983-91. PubMed ID: 21052642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of bisphosphonates utilization in patients under age 45 in a large cohort of commercial insurance beneficiaries in the United States.
    Xie J; Tong A; Kim SC
    PLoS One; 2015; 10(1):e0115091. PubMed ID: 25611596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for older men with fractures.
    Shepherd AJ; Cass AR; Ray LA; Tan A; Wilkinson GS
    Osteoporos Int; 2012 Mar; 23(3):1041-51. PubMed ID: 21811867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
    Riska BSL; Gunnes N; Stigum H; Finnes TE; Meyer HE; Omsland TK; Holvik K
    Osteoporos Int; 2023 Aug; 34(8):1369-1379. PubMed ID: 37100950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
    Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
    Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
    Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
    Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.